- The MEA market is witnessing strong growth due to rising consumer demand for minimally invasive cosmetic procedures and the growing presence of aesthetic clinics in countries like UAE, Saudi Arabia, and South Africa
- Countries such as the UAE are benefiting from government-backed healthcare infrastructure development and a growing influx of international aesthetic dermatology brands
- The botulinum toxin segment, including botulinum toxin and dermal fillers, is expected to dominate the market with a market share exceeding 41.30% by 2025, driven by its widespread use for wrinkle reduction and facial rejuvenation. The increasing demand for non-invasive, effective treatments among both men and women will drive growth in this segment.
